123 related articles for article (PubMed ID: 21061787)
1. Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501).
Niibe Y; Watanabe J; Tsunoda S; Arai M; Arai T; Kawaguchi M; Matsuo K; Jobo T; Ono S; Numata A; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2010; 31(5):491-6. PubMed ID: 21061787
[TBL] [Abstract][Full Text] [Related]
2. Pulsatility Index and Hypoxia Inducible Factor-1α Expression Predict the Clinical Response after External Radiation in Patients with Stage IIB to IVA Cervical Cancer.
Winata IGS; Hidayat YM; Winarno GN; Suardi D; Soetopo S; Suwiyoga K
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2073-2078. PubMed ID: 31350968
[TBL] [Abstract][Full Text] [Related]
3. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.
Burri P; Djonov V; Aebersold DM; Lindel K; Studer U; Altermatt HJ; Mazzucchelli L; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):494-501. PubMed ID: 12738326
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
6. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy.
Bache M; Holzapfel D; Kappler M; Holzhausen HJ; Taubert H; Dunst J; Hänsgen G
Gynecol Oncol; 2007 Jan; 104(1):139-44. PubMed ID: 16919715
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
11. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-based radiochemotherapy improves the negative prognosis of c-erbB-2 overexpressing advanced cervical cancer.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Alonso-Carrión L; Mendiola C; Lanzós E
Int J Gynecol Cancer; 2010 Jan; 20(1):164-72. PubMed ID: 20057287
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
16. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
18. Vasculogenic mimicry and hypoxia-inducible factor-1α expression in cervical squamous cell carcinoma.
Zhou TJ; Huang XH; Gong L; Xiang L
Genet Mol Res; 2016 Mar; 15(1):15017396. PubMed ID: 26985936
[TBL] [Abstract][Full Text] [Related]
19. Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer.
Fujimoto J; Alam SM; Jahan I; Sato E; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Cancer Sci; 2006 Sep; 97(9):861-7. PubMed ID: 16805819
[TBL] [Abstract][Full Text] [Related]
20. Associations between whole tumor histogram analysis parameters derived from ADC maps and expression of EGFR, VEGF, Hif 1-alpha, Her-2 and Histone 3 in uterine cervical cancer.
Meyer HJ; Gundermann P; Höhn AK; Hamerla G; Surov A
Magn Reson Imaging; 2019 Apr; 57():68-74. PubMed ID: 30367998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]